Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group.
Journal: Innovations in clinical neuroscience
Published: March 18, 2024
Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study.
Journal: Schizophrenia bulletin
Published: October 28, 2022
Respiratory-gated auricular vagal afferent nerve stimulation (RAVANS) modulates brain response to stress in major depression.
Journal: Journal of psychiatric research
Published: February 19, 2021
Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3).
Journal: Neuropsychiatric disease and treatment
Published: May 02, 2019
Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: January 30, 2019
Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia.
Journal: CNS spectrums
Published: August 16, 2018
Switching stable patients with schizophrenia from their oral antipsychotics to aripiprazole lauroxil: a post hoc safety analysis of the initial 12-week crossover period.
Journal: CNS spectrums
Published: June 27, 2018
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled Study.
Journal: Journal of clinical pharmacology
Published: June 04, 2018
Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study.
Journal: Psychiatry research
Published: May 30, 2018
Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial.
Journal: Journal of clinical pharmacology
Published: March 31, 2018
Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies.
Journal: Molecular psychiatry
Published: March 30, 2018
Long-range gamma phase synchronization as a compensatory strategy during working memory in high-performing patients with schizophrenia.
Journal: Journal of clinical and experimental neuropsychology
Published: February 02, 2018
Last Updated: 09/26/2026